Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Mousa Ahmad Al Hiyari"'
Autor:
Fateen Ata, Zohaib Yousaf, Fathima Z. Zahir, Anas Mohamed Babiker, Amer Ali Farooqi, Mousa Ahmad Al Hiyari, Adel Issam Al Bozom, Ahmed Hatim. Mohamed, Abdulqadir J. Nashwan, Mohamed A. Yassin
Publikováno v:
Qatar Medical Journal. 2022
Rituximab is used as second-line therapy in patients with immune thrombocytopenic purpura (ITP) who do not respond to first-line management. The response rate for Rituximab is variable in different populations ranging from 30% to 90%. The adverse eff